Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut H Malluche

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2010
Sclerostin and Dickkopf-1 in renal osteodystrophyDaniel Cejka, Johann Herberth, Adam J Branscum, et al.
Kidney International|July 9, 2003
Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal diseaseB Peter Sawaya, Rezkalla Butros, Shehzab Naqvi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2009
Low bone volume--a risk factor for coronary calcifications in hemodialysis patientsTeresa Adragao, Johann Herberth, Marie-Claude Monier-Faugere, et al.
Kidney International|August 28, 2017
The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney diseaseMatthew J Williams, Toshifumi Sugatani, Olga A Agapova, et al.
Kidney International|September 27, 2016
Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney diseaseToshifumi Sugatani, Olga A Agapova, Yifu Fang, et al.
Kidney International Reports|May 16, 2022
Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKDAmr El-Husseini, Mohamed Abdalbary, Florence Lima, et al.
Kidney International Reports|January 1, 2020
Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular CalcificationDaniel W Coyne, Hem N Singh, William T Smith, et al.
Canadian Journal of Kidney Health and Disease|March 1, 2019
A Survey Study of Self-Rated Patients' Knowledge About AKI in a Post-Discharge AKI ClinicVictor Ortiz-Soriano, Joseph L Alcorn, Xilong Li, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 17, 2010
The link between bone and coronary calcifications in CKD-5 patients on haemodialysisGulay Asci, Ercan Ok, Recep Savas, et al.
Kidney International|August 17, 2016
Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney diseaseDaniel Cejka, Diego Parada-Rodriguez, Stefanie Pichler, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2010
Sclerostin and Dickkopf-1 in renal osteodystrophyDaniel Cejka, Johann Herberth, Adam J Branscum, et al.
Kidney International|July 9, 2003
Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal diseaseB Peter Sawaya, Rezkalla Butros, Shehzab Naqvi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2009
Low bone volume--a risk factor for coronary calcifications in hemodialysis patientsTeresa Adragao, Johann Herberth, Marie-Claude Monier-Faugere, et al.
Kidney International|August 28, 2017
The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney diseaseMatthew J Williams, Toshifumi Sugatani, Olga A Agapova, et al.
Kidney International|September 27, 2016
Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney diseaseToshifumi Sugatani, Olga A Agapova, Yifu Fang, et al.
Kidney International Reports|May 16, 2022
Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKDAmr El-Husseini, Mohamed Abdalbary, Florence Lima, et al.
Kidney International Reports|January 1, 2020
Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular CalcificationDaniel W Coyne, Hem N Singh, William T Smith, et al.
Canadian Journal of Kidney Health and Disease|March 1, 2019
A Survey Study of Self-Rated Patients' Knowledge About AKI in a Post-Discharge AKI ClinicVictor Ortiz-Soriano, Joseph L Alcorn, Xilong Li, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 17, 2010
The link between bone and coronary calcifications in CKD-5 patients on haemodialysisGulay Asci, Ercan Ok, Recep Savas, et al.
Kidney International|August 17, 2016
Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney diseaseDaniel Cejka, Diego Parada-Rodriguez, Stefanie Pichler, et al.
Pageof 7